{"count": 150, "results": [{"_id": "37483818", "pmid": 37483818, "pmcid": "PMC10362193", "title": "Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease", "journal": "Heliyon", "authors": ["Rabieipoor S", "Zare M", "Ettcheto M", "Camins A", "Javan M"], "date": "2023-06-30T00:00:00Z", "doi": "10.1016/j.heliyon.2023.e17873", "meta_date_publication": "2023 Jul", "meta_volume": "9", "meta_issue": "7", "meta_pages": "e17873", "score": 50275.355, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduced dying neurons in @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@SAD@@@ mice", "citations": {"NLM": "Rabieipoor S, Zare M, Ettcheto M, Camins A, Javan M. Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease Heliyon. 2023 Jul;9(7):e17873. PMID: 37483818", "BibTeX": "@article{37483818, title={Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease}, author={Rabieipoor S and Zare M and Ettcheto M and Camins A and Javan M}, journal={Heliyon}, volume={9}, number={7}, pages={e17873}}"}}, {"_id": "36422837", "pmid": 36422837, "pmcid": "PMC10121992", "title": "Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice", "journal": "Neurotherapeutics", "authors": ["Zhao S", "Fan Z", "Zhang X", "Li Z", "Shen T", "Li K", "Yan Y", "Yuan Y", "Pu J", "Tian J", "Liu Z", "Chen Y", "Zhang B"], "date": "2022-11-23T00:00:00Z", "doi": "10.1007/s13311-022-01316-6", "meta_date_publication": "2022 Nov 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50270.61, "text_hl": "These findings highlight the potential mechanisms underlying the beneficial effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on cognition, implying that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could be a promising drug for the prevention and early treatment of @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@AD@@@.", "citations": {"NLM": "Zhao S, Fan Z, Zhang X, Li Z, Shen T, Li K, Yan Y, Yuan Y, Pu J, Tian J, Liu Z, Chen Y, Zhang B. Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice Neurotherapeutics. 2022 Nov 23;():. PMID: 36422837", "BibTeX": "@article{36422837, title={Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice}, author={Zhao S and Fan Z and Zhang X and Li Z and Shen T and Li K and Yan Y and Yuan Y and Pu J and Tian J and Liu Z and Chen Y and Zhang B}, journal={Neurotherapeutics}}"}}, {"_id": "34577590", "pmid": 34577590, "pmcid": "PMC8465337", "title": "Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment", "journal": "Pharmaceuticals (Basel)", "authors": ["Poor SR", "Ettcheto M", "Cano A", "Sanchez-Lopez E", "Manzine PR", "Olloquequi J", "Camins A", "Javan M"], "date": "2021-09-01T00:00:00Z", "doi": "10.3390/ph14090890", "meta_date_publication": "2021 Sep 1", "meta_volume": "14", "meta_issue": "9", "meta_pages": "", "score": 50269.79, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ a Potential Pharmacological Strategy in Late Onset @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@Alzheimer's Disease@@@ Treatment", "citations": {"NLM": "Poor SR, Ettcheto M, Cano A, Sanchez-Lopez E, Manzine PR, Olloquequi J, Camins A, Javan M. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment Pharmaceuticals (Basel). 2021 Sep 1;14(9):. PMID: 34577590", "BibTeX": "@article{34577590, title={Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment}, author={Poor SR and Ettcheto M and Cano A and Sanchez-Lopez E and Manzine PR and Olloquequi J and Camins A and Javan M}, journal={Pharmaceuticals (Basel)}, volume={14}, number={9}}"}}, {"_id": "37780174", "pmid": 37780174, "pmcid": "PMC10540612", "title": "Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation", "journal": "Ther Adv Endocrinol Metab", "authors": ["Shi X", "Li L", "Liu Z", "Wang F", "Huang H"], "date": "2023-09-27T00:00:00Z", "doi": "10.1177/20420188231187493", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "20420188231187493", "score": 50267.734, "text_hl": "To study the potential mechanism of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ action in @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@AD@@@ and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D", "citations": {"NLM": "Shi X, Li L, Liu Z, Wang F, Huang H. Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation Ther Adv Endocrinol Metab. 2023;14():20420188231187493. PMID: 37780174", "BibTeX": "@article{37780174, title={Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation}, author={Shi X and Li L and Liu Z and Wang F and Huang H}, journal={Ther Adv Endocrinol Metab}, volume={14}, pages={20420188231187493}}"}}, {"_id": "35077762", "pmid": 35077762, "title": "Exploring the dual character of metformin in Alzheimer's disease.", "journal": "Neuropharmacology", "authors": ["Ning P", "Luo A", "Mu X", "Xu Y", "Li T"], "date": "2022-04-01T00:00:00Z", "doi": "10.1016/j.neuropharm.2022.108966", "meta_date_publication": "2022 Apr 1", "meta_volume": "207", "meta_issue": "", "meta_pages": "108966", "score": 50267.29, "text_hl": "Exploring the dual character of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@.", "citations": {"NLM": "Ning P, Luo A, Mu X, Xu Y, Li T. Exploring the dual character of metformin in Alzheimer's disease. Neuropharmacology. 2022 Apr 1;207():108966. PMID: 35077762", "BibTeX": "@article{35077762, title={Exploring the dual character of metformin in Alzheimer's disease.}, author={Ning P and Luo A and Mu X and Xu Y and Li T}, journal={Neuropharmacology}, volume={207}, pages={108966}}"}}, {"_id": "35153733", "pmid": 35153733, "pmcid": "PMC8829062", "title": "Deciphering the Roles of Metformin in Alzheimer's Disease: A Snapshot", "journal": "Front Pharmacol", "authors": ["Liao W", "Xu J", "Li B", "Ruan Y", "Li T", "Liu J"], "date": "2022-01-27T00:00:00Z", "doi": "10.3389/fphar.2021.728315", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "728315", "score": 50267.29, "text_hl": "Deciphering the Roles of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@Alzheimer's Disease@@@: A Snapshot", "citations": {"NLM": "Liao W, Xu J, Li B, Ruan Y, Li T, Liu J. Deciphering the Roles of Metformin in Alzheimer's Disease: A Snapshot Front Pharmacol. 2021;12():728315. PMID: 35153733", "BibTeX": "@article{35153733, title={Deciphering the Roles of Metformin in Alzheimer's Disease: A Snapshot}, author={Liao W and Xu J and Li B and Ruan Y and Li T and Liu J}, journal={Front Pharmacol}, volume={12}, pages={728315}}"}}, {"_id": "34999113", "pmid": 34999113, "title": "Mechanistic insight into the role of metformin in Alzheimer's disease.", "journal": "Life Sci", "authors": ["Sanati M", "Aminyavari S", "Afshari AR", "Sahebkar A"], "date": "2022-02-15T00:00:00Z", "doi": "10.1016/j.lfs.2021.120299", "meta_date_publication": "2022 Feb 15", "meta_volume": "291", "meta_issue": "", "meta_pages": "120299", "score": 50267.03, "text_hl": "Mechanistic insight into the role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@.", "citations": {"NLM": "Sanati M, Aminyavari S, Afshari AR, Sahebkar A. Mechanistic insight into the role of metformin in Alzheimer's disease. Life Sci. 2022 Feb 15;291():120299. PMID: 34999113", "BibTeX": "@article{34999113, title={Mechanistic insight into the role of metformin in Alzheimer's disease.}, author={Sanati M and Aminyavari S and Afshari AR and Sahebkar A}, journal={Life Sci}, volume={291}, pages={120299}}"}}, {"_id": "37874091", "pmid": 37874091, "title": "Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias.", "journal": "J Prev Alzheimers Dis", "authors": ["Tahmi M", "Luchsinger JA"], "date": "2023-01-01T00:00:00Z", "doi": "10.14283/jpad.2023.113", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "4", "meta_pages": "706-717", "score": 50265.48, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in the Prevention of @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@Alzheimer's Disease@@@ and @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@Alzheimer's Disease@@@ Related @DISEASE_Dementia @DISEASE_MESH:D003704 @@@Dementias@@@.", "citations": {"NLM": "Tahmi M, Luchsinger JA. Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias. J Prev Alzheimers Dis. 2023;10(4):706-717. PMID: 37874091", "BibTeX": "@article{37874091, title={Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias.}, author={Tahmi M and Luchsinger JA}, journal={J Prev Alzheimers Dis}, volume={10}, number={4}, pages={706-717}}"}}, {"_id": "39422959", "pmid": 39422959, "title": "Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias.", "journal": "J Alzheimers Dis", "authors": ["Tahmi M", "Benitez R", "Luchsinger JA"], "date": "2024-01-01T00:00:00Z", "doi": "10.3233/JAD-240495", "meta_date_publication": "2024", "meta_volume": "101", "meta_issue": "s1", "meta_pages": "S345-S356", "score": 50262.434, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as a Potential Prevention Strategy for @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@Alzheimer's Disease@@@ and @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@Alzheimer's Disease@@@ Related @DISEASE_Dementia @DISEASE_MESH:D003704 @@@Dementias@@@.", "citations": {"NLM": "Tahmi M, Benitez R, Luchsinger JA. Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias. J Alzheimers Dis. 2024;101(s1):S345-S356. PMID: 39422959", "BibTeX": "@article{39422959, title={Metformin as a Potential Prevention Strategy for Alzheimer's Disease and Alzheimer's Disease Related Dementias.}, author={Tahmi M and Benitez R and Luchsinger JA}, journal={J Alzheimers Dis}, volume={101}, number={s1}, pages={S345-S356}}"}}, {"_id": "37090575", "pmid": 37090575, "pmcid": "PMC10120765", "title": "Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data", "journal": "Res Sq", "authors": ["Tao C", "Lundin S", "Hu X", "Feng J", "Lundin K", "Chen Y"], "date": "2023-04-13T00:00:00Z", "doi": "10.21203/rs.3.rs-2629005/v1", "meta_date_publication": "2023 Apr 13", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50261.918, "text_hl": "On the other hand, the use of these AHMs without @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ was associated with a 3% and 2% lower risk of @<m>DISEASE_Alzheimer_Disease</m> @DISEASE_MESH:D000544 @@@ADRD@@@, respectively. ", "citations": {"NLM": "Tao C, Lundin S, Hu X, Feng J, Lundin K, Chen Y. Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data Res Sq. 2023 Apr 13;():. PMID: 37090575", "BibTeX": "@article{37090575, title={Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data}, author={Tao C and Lundin S and Hu X and Feng J and Lundin K and Chen Y}, journal={Res Sq}}"}}]}